Stock Market & Financial Investment News

News Breaks October 3, 2012 06:47 EDT THOR Thoratec upgraded to Buy from Neutral at UBS UBS upgraded Thoratec due to valuation and its ability to grow through its HVAD launch. Price target raised to $39 from $35. News For THOR From The Last 14 Days Check below for free stories on THOR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 17, 2013 08:04 EDT THOR Thoratec announces FDA approval of HeartMate II Pocket Controller Thoratec announced that it has received approval from the FDA to market the HeartMate II Pocket Controller, the small, smart, safe face of the HeartMate II LVAD System. May 13, 2013 10:09 EDT THOR On The Fly: Analyst Downgrade Summary Subscribe for More Information 07:31 EDT THOR Thoratec downgraded to Neutral from Buy at Lazard Capital Subscribe for More Information May 6, 2013 10:04 EDT THOR On The Fly: Analyst Upgrade Summary Subscribe for More Information 06:20 EDT THOR Thoratec upgraded to Neutral from Underperform at Credit Suisse Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.